Valley National Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,505
| Closed | -$2K | – | 1018 |
|
|
2022
Q3 | $2K | Hold |
1,505
| – | – | ﹤0.01% | 807 |
|
|
2022
Q2 | $3K | Hold |
1,505
| – | – | ﹤0.01% | 744 |
|
|
2022
Q1 | $3K | Hold |
1,505
| – | – | ﹤0.01% | 772 |
|
|
2021
Q4 | $4K | Hold |
1,505
| – | – | ﹤0.01% | 726 |
|
|
2021
Q3 | $7K | Buy |
1,505
+1,000
| +198% | +$4.65K | ﹤0.01% | 633 |
|
|
2021
Q2 | $3K | Hold |
505
| – | – | ﹤0.01% | 761 |
|
|
2021
Q1 | $4K | Hold |
505
| – | – | ﹤0.01% | 675 |
|
|
2020
Q4 | $2K | Hold |
505
| – | – | ﹤0.01% | 716 |
|
|
2020
Q3 | $3K | Hold |
505
| – | – | ﹤0.01% | 637 |
|
|
2020
Q2 | $3K | Hold |
505
| – | – | ﹤0.01% | 632 |
|
|
2020
Q1 | $3K | Hold |
505
| – | – | ﹤0.01% | 622 |
|
|
2019
Q4 | $5K | Hold |
505
| – | – | ﹤0.01% | 616 |
|
|
2019
Q3 | $2K | Buy |
+505
| New | +$2K | ﹤0.01% | 694 |
|